Page last updated: 2024-09-03

ym 022 and Argentaffinoma

ym 022 has been researched along with Argentaffinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, EK; Hayes, MM; Kang, AJ; Merchant, JL; Sundaresan, S1
Ahlman, H; Kölby, L; Modlin, IM; Nilsson, O; Theodorsson, E; Wängberg, B1

Other Studies

2 other study(ies) available for ym 022 and Argentaffinoma

ArticleYear
Deletion of
    Gut, 2017, Volume: 66, Issue:6

    Topics: Adenocarcinoma; Adult; Animals; Benzodiazepines; Carcinogenesis; Carcinoid Tumor; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastrins; Gene Deletion; Hormone Antagonists; Hormones; Humans; Male; Mice; Mice, Transgenic; Omeprazole; Phosphorylation; Proto-Oncogene Proteins; Proton Pump Inhibitors; Receptor, Cholecystokinin B; RNA, Messenger; Signal Transduction; Somatostatin; Stomach Neoplasms

2017
Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.
    Regulatory peptides, 1999, Dec-23, Volume: 85, Issue:2-3

    Topics: Animals; Benzodiazepines; Carcinoid Tumor; Cell Transformation, Neoplastic; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Gene Expression; Histamine H2 Antagonists; Histidine Decarboxylase; Hormone Antagonists; Humans; Muridae; Receptors, Cholecystokinin; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Triazoles

1999